STERIS plc (STE)

NYQ – Real Time Price. Currency in USD

236.29

-1.94 (-0.81%)

Market open: Aug 12, 2026, 12:55 PM EDT

238.23

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

09.08.2026

STERIS Q1 Earnings Call Highlights

STERIS NYSE: STE reported first-quarter fiscal 2027 revenue growth and higher earnings, while maintaining its full-year outlook and outlining a $600 million investment in a new chemistry manufacturing, research and distribution complex in North Carolina.

06.08.2026

STERIS plc (STE) Q1 2027 Earnings Call Transcript

06.08.2026

STE Q1 Earnings Beat, Revenues Miss, Stock Dips in Aftermarket Trading

STERIS beats fiscal Q1 earnings estimates as sales rise 7.3%, but a modest revenue miss sends shares 2.4% lower after hours.

06.08.2026

5 Quality Stocks Set to Reward Investors With Dividend Hikes

Recent dividend hikes from DRH, STE, BCC, KWR and WHD highlight financially solid companies as investors seek stability in a mixed market.

05.08.2026

Here's What Key Metrics Tell Us About Steris (STE) Q1 Earnings

While the top- and bottom-line numbers for Steris (STE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

05.08.2026

Steris (STE) Q1 Earnings Surpass Estimates

Steris (STE) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.54 per share. This compares to earnings of $2.34 per share a year ago.

05.08.2026

STERIS Announces Financial Results for Fiscal 2027 First Quarter

DUBLIN, IRELAND, Aug. 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2027 first quarter ended June 30, 2026. Total revenue for the first quarter of fiscal 2027 increased 7% to $1.5 billion compared with $1.4 billion in the first quarter of fiscal 2026. Constant currency organic revenue growth was 6% in the first quarter.

Videos

No Data

There is no data to display

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
STE	UBS	Buy	undefined >> $275	July 28th 2026

Press releases

05.08.2026

STERIS Announces Financial Results for Fiscal 2027 First Quarter

05.08.2026

STERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolina

• This Formulated Chemistries Center of Excellence will support sterilization and disinfection for the global Healthcare and Pharmaceutical industries

STERIS plc (STE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us